Podcast: Download (Duration: 1:08 — 1.6MB)
Subscribe: RSS
A blood test used for population based cancer screening fell short of allowing cancers to be detected earlier, was cost prohibitive and delayed diagnoses for others, a new study shows. Johns Hopkins Kimmel Cancer Center director William Nelson says both …
Podcast: Download (Duration: 1:06 — 1.5MB)
Subscribe: RSS
When large populations of people were screened for multiple cancers using a blood test, not only didn’t cancers get found earlier, others who were not screened had delays in their diagnosis and treatment of cancer. Johns Hopkins Kimmel Cancer Center …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
GLP-1 agonists are a class of drugs originally developed to treat diabetes but have been shown to be helpful for weight loss. Now a new study looks at whether their use reduces the risk of obesity related cancers. William Nelson, …
How are one class of diabetes drugs related to cancer risk? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:01 — 1.4MB)
Subscribe: RSS
Making CAR-T cells from donor bone marrow already used to treat someone’s cancer helped rein in cancer recurrence, a new study shows. Kimmel Cancer Center director William Nelson at Johns Hopkins says this is one more place where an expansion …
Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
CAR-T cells developed from bone marrow donors whose bone marrow had already been used to treat someone’s cancer may be able to rein in cancer recurrence, a new study finds. Johns Hopkins Kimmel Cancer Center director William Nelson says this …
Can donor CAR-T cells have an impact on cancer treatment? Elizabeth Tracey reports Read more »
